Research - Saint-Herblain, Pays de la Loire, France
Unraveling the potential of microalgae for the biomanufacturing of therapeuric proteinsCompany ProfileALGENICS is a biotechnology company focused on innovative uses of microalgae to produce recombinant biotherapeutics. Our platform of synthetic biology AlgebiosysTM encompasses tools and technologies to efficiently generate stable strain of high-producing microalgal cells. This proprietary and patented platform allows the biomanufacturing of a broad range of therapeutics in our PTA cell line, including glycoproteins and cytotoxics.ALGENICS was founded in 2008 as a spin-off from IFREMER (The French Research Institute for Exploitation of the Sea) and opened in 2009 its own facility in Nantes (France).
Gmail
Google Font API
Google Apps
DigitalOcean
Bootstrap Framework